Search Result "Proprotein Convertase Subtilisin/Kexin9 (PCSK9)"


Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation

Journal: Protein & Peptide Letters
Volume: 19 Issue: 6 Year: 2012 Page: 575-585
Author(s): Ajoy Basak,Heather Palmer-Smith,Priyambada Mishra

Regulatory Effects of Peptides from the Pro and Catalytic Domains of Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) on Low-Density Lipoprotein Receptor (LDL-R)

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 2168-2182
Author(s): H. Palmer-Smith, A. Basak

Review Article

PCSK9 Inhibitors and Cardiovascular Disease: Impact on Cardiovascular Outcomes

Journal: Current Drug Discovery Technologies
Volume: 17 Issue: 2 Year: 2020 Page: 138-146
Author(s): Paraskevi Farmaki,Christos Damaskos,Nikolaos Garmpis,Anna Garmpi,Spyridon Savvanis,Evangelos Diamantis

Review Article

The Link between miRNAs and PCKS9 in Atherosclerosis

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 42 Year: 2024 Page: 6926-6956
Author(s): Mirjana T. Macvanin,Zoran M. Gluvic,Aleksandra N. Klisic,Mia S. Manojlovic,Jasjit S. Suri,Esma R. Isenovic

Systematic Review Article

Efficacy and Safety of Alirocumab and Evolocumab as ProproteinConvertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors in FamilialHypercholesterolemia: A Systematic Review and Meta-Analysis

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 2 Year: 2024 Page: 223-241
Author(s): Ali Akbar Soleimani

Results 1 - 1 of 5

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy